blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1385498

EP1385498 - Fatty acids as neutrophil survival and activation factors. [Right-click to bookmark this link]
Former [2004/06]MEDIUM-CHAIN LENGTH FATTY ACIDS, GLYCERIDES AND ANALOGUES AS NEUTROPHIL SURVIVAL AND ACTIVATION FACTORS
[2007/17]
StatusNo opposition filed within time limit
Status updated on  26.09.2008
Database last updated on 16.11.2024
Most recent event   Tooltip09.07.2010Lapse of the patent in a contracting state
New state(s): LU
published on 11.08.2010  [2010/32]
Applicant(s)For all designated states
ProMetic BioSciences Inc.
8168 Montview Mont-Royal
Québec H4P 2L7 / CA
[2007/47]
Former [2004/06]For all designated states
Prometic Biosciences Inc.
6100 Avenue Royalmount
Montreal, Quebec H4P 2R2 / CA
Inventor(s)01 / GAGNON, Lyne
1973 de la Victoire
Laval, Quebec H7M 3E5 / CA
02 / BARABE, Jean
3500 Place Joseph N. Drapeau, Apt. 301
Montreal, Quebec H1X 3J1 / CA
03 / LAURIN, Pierre, ProMetic BioSciences Inc
8168 Chemin Mountview
Montreal, Quebec H4P 2L7 / CA
04 / PENNEY, Christopher
12787 Joron
Pierrfonds, Quebec H8Z 3K7 / CA
05 / ZACHARIE, Boulos
3202 Honore de Balzac
Laval, Quebec H7P 5Y3 / CA
 [2004/12]
Former [2004/06]01 / GAGNON, Lyne
1973 de la Victoire
Laval, Quebec H7M 3E5 / CA
02 / BARABE, Jean
3500 Place Joseph N. Drapeau, Apt. 301
Montreal, Quebec H1X 3J1 / CA
03 / LAURIN, Pierre
873 Joseph Quintal
Montreal, Quebec H2M 2M9 / CA
04 / PENNEY, Christopher
12787 Joron
Pierrfonds, Quebec H8Z 3K7 / CA
05 / ZACHARIE, Boulos
3202 Honore de Balzac
Laval, Quebec H7P 5Y3 / CA
Representative(s)Perry, Robert Edward, et al
Gill Jennings & Every LLP The Broadgate Tower
20 Primrose Street
London
EC2A 2ES / GB
[N/P]
Former [2004/06]Perry, Robert Edward, et al
GILL JENNINGS & EVERY Broadgate House 7 Eldon Street
London EC2M 7LH / GB
Application number, filing date02761857.818.04.2002
[2004/06]
WO2002CA00535
Priority number, dateUS20010284458P18.04.2001         Original published format: US 284458 P
[2004/06]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO02083120
Date:24.10.2002
Language:EN
[2002/43]
Type: A2 Application without search report 
No.:EP1385498
Date:04.02.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 24.10.2002 takes the place of the publication of the European patent application.
[2004/06]
Type: B1 Patent specification 
No.:EP1385498
Date:21.11.2007
Language:EN
[2007/47]
Search report(s)International search report - published on:EP22.05.2003
ClassificationIPC:A61K31/20, A61P7/06
[2007/17]
CPC:
C07C237/22 (EP,US); A61K31/20 (EP,KR,US); A61K31/18 (EP,US);
A61K31/194 (EP,US); A61K31/23 (EP,US); A61K31/255 (EP,US);
A61K31/7024 (EP,US); A61K38/193 (EP,US); A61K38/2013 (EP,US);
A61K38/2086 (EP,US); A61K45/06 (EP,US); A61P17/02 (EP);
A61P3/02 (EP); A61P31/00 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P37/04 (EP); A61P43/00 (EP);
A61P7/00 (EP); A61P7/06 (EP); C07C233/18 (EP,US);
C07C233/47 (EP,US); C07C235/06 (EP,US); C07C235/08 (EP,US);
C11C3/003 (EP,US); C11C3/02 (EP,US); C07B2200/11 (EP,US);
C40B40/00 (EP,US); Y02A50/30 (EP,US) (-)
C-Set:
A61K31/23, A61K2300/00 (US,EP);
A61K31/23, A61K31/20 (US,EP);
A61K31/23, A61K31/23 (EP,US);
A61K38/193, A61K2300/00 (US,EP);
A61K38/2013, A61K2300/00 (EP,US);
A61K38/2086, A61K2300/00 (EP,US)
(-)
Former IPC [2004/06]A61K31/20, A61K31/23, A61K31/255, A61K31/7024, A61P7/06, A61K31/18, A61K31/194, C07H15/04, C07C233/18, C07C233/47, C07C235/06, C07C235/08, C07C237/22
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/06]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RO06.11.2003
SI06.11.2003
TitleGerman:Fettsäuren als Faktoren für das Überleben und die Aktivierung von Neutrophilen.[2007/17]
English:Fatty acids as neutrophil survival and activation factors.[2007/17]
French:Acides gras à longuer utilisés de survie et d'activation des neutrophiles.[2007/17]
Former [2004/06]FETTSÄUREN MITTLERER KETTENLÄNGE, GLYCERIDE UND ANALOGA ALS FAKTOREN FÜR DAS ÜBERLEBEN UND DIE AKTIVIERUNG VON NEUTROPHILEN
Former [2004/06]MEDIUM-CHAIN LENGTH FATTY ACIDS, GLYCERIDES AND ANALOGUES AS NEUTROPHIL SURVIVAL AND ACTIVATION FACTORS
Former [2004/06]ACIDES GRAS A LONGUEUR DE CHAINE MOYENNE, GLYCERIDES ET ANALOGUES DE CES ACIDES, UTILISES COMME FACTEURS DE SURVIE ET D'ACTIVATION DES NEUTROPHILES
Entry into regional phase06.11.2003National basic fee paid 
06.11.2003Designation fee(s) paid 
06.11.2003Examination fee paid 
Examination procedure15.11.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
30.10.2003Amendment by applicant (claims and/or description)
06.11.2003Examination requested  [2004/06]
19.04.2005Despatch of a communication from the examining division (Time limit: M02)
08.06.2005Reply to a communication from the examining division
31.01.2006Despatch of a communication from the examining division (Time limit: M04)
06.06.2006Reply to a communication from the examining division
16.03.2007Cancellation of oral proceeding that was planned for 19.04.2007
16.03.2007Minutes of oral proceedings despatched
19.04.2007Date of oral proceedings (cancelled)
25.05.2007Communication of intention to grant the patent
17.09.2007Fee for grant paid
17.09.2007Fee for publishing/printing paid
Divisional application(s)EP07116425.5  / EP1900364
Opposition(s)22.08.2008No opposition filed within time limit [2008/44]
Fees paidRenewal fee
15.04.2004Renewal fee patent year 03
13.04.2005Renewal fee patent year 04
27.03.2006Renewal fee patent year 05
16.04.2007Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipLU18.04.2008
MC30.04.2008
[2010/32]
Former [2008/51]MC30.04.2008
Cited inInternational search[X]WO8902275  (NEW ENGLAND DEACONESS HOSPITAL [US]) [X] 1-5,13-31,54,55 * claims 7-17 *;
 WO9530413  [ ] (KITASATO INST [JP], et al);
 [X]WO9926640  (BUKWANG PHARM IND CO LTD [KR], et al) [X] 1-5,13-31,54,55 * page 5, line 20 - page 6, line 18 * * page 13, line 1 - page 15, line 18 * * claims 7,8 *;
 [PX]WO0195914  (PORTER WILLIAM LESLIE [GB]) [PX] 1-6,8,10-31,54,55* the whole document *;
 [X]  - YAMADA, HARUKI ET AL, "Hematopoietic stem cell proliferation accelerator", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 124:97756 HCA, URL: STN, XP002215684 [X] 1-6,8,10-31,54,55 * abstract *
 [X]  - PAGEAU R ET AL, "SYSTEMIC PROTECTION AGAINST RADIATION PART 2 EFFECT OF PROTEIN AND LIPID CONSTITUENTS OF DIET", RADIATION RESEARCH, (1976), vol. 66, no. 2, ISSN 0033-7587, pages 267 - 273, XP008007909 [X] 1-5,13-31,54,55 * the whole document *
 [AD]  - DEMIRER S ET AL, "Comparison of the efficacy of medium chain triglycerides with long chain triglycerides in total parenteral nutrition in patients with hematologic malignancies undergoing peripheral blood stem cell transplantation.", CLINICAL NUTRITION (EDINBURGH), (200008), vol. 19, no. 4, ISSN 0261-5614, pages 253 - 258, XP008007854 [AD] 1-6,8,10-31,54,55 * the whole document *

DOI:   http://dx.doi.org/10.1054/clnu.2000.0101
 [A]  - WANTEN G ET AL, "Nutritional lipid emulsions modulate cellular signaling and activation of human neutrophils.", JOURNAL OF LIPID RESEARCH, (200103), vol. 42, no. 3, ISSN 0022-2275, pages 428 - 436, XP008007838 [A] 1-6,8,10-31,54,55 * the whole document *
 [A]  - BEAU PHILIPPE ET AL, "Comparison of bone marrow toxicity of medium-chain and long-chain triglyceride emulsions: An in vitro study in humans.", JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, (199711), vol. 21, no. 6, ISSN 0148-6071, pages 343 - 346, XP008007856 [A] 1-6,8,10-31,54,55 * the whole document *
 [A]  - WANTEN GEERT J ET AL, "Phagocytosis and killing of Candida albicans by human neutrophils after exposure to structurally different lipid emulsions.", JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, (200101), vol. 25, no. 1, ISSN 0148-6071, pages 9 - 13, XP008007855 [A] 1-6,8,10-31,54,55 * the whole document *
 [A]  - KIMOTO YASHUHIKO ET AL, "Antitumor effect of medium-chain triglyceride and its influence on the self-defense system of the body.", CANCER DETECTION AND PREVENTION, (1998), vol. 22, no. 3, ISSN 0361-090X, pages 219 - 224, XP008007907 [A] 1-6,8,10-31,54,55 * the whole document *

DOI:   http://dx.doi.org/10.1046/j.1525-1500.1998.0OA32.x
 [A]  - BEERS, M.H., ET. AL., The Merck Manual of Diagnosis and Therapy, NEW YORK, USA, MERCK RESEARCH LABORATORIES, (1999), XP002216068 [A] 1-6,8,10-31,54,55 * page 931 - page 933 *
 [PX]  - WANTEN, G.J.A., ET. AL.,, "Saturated triglycerides and fatty acids activate neutrophils depending on carbon chain-length", EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, vol. 32, no. 4, pages 285 - 289, XP002215683 [PX] 1-6,8,10-31,54,55 * the whole document *

DOI:   http://dx.doi.org/10.1046/j.1365-2362.2002.00959.x
ExaminationUS4816440
    - HIROKO HISHA ET AL, "Isolation and Identification of Hematopoietic Stem Cell-Stimulating Substances from Kampo (Japanese Herbal) Medicine, Juzen-Taiho-To", BLOOD, (1997), vol. 90, no. 3, pages 1022 - 1030, XP008119841
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.